Literature DB >> 20687846

Pustulosis palmoplantaris is a disease distinct from psoriasis.

Anne C de Waal1, Peter C M van de Kerkhof.   

Abstract

Pustulosis palmoplantaris (PPP) is a chronic inflammatory skin disease with a considerable impairment of quality of life and is characterized by sterile pustules and red, scaly skin on the palms and soles. The position of PPP in relation to psoriasis is unclear. Some authors regard PPP as a distinct disease entity, whereas others categorize PPP as a manifestation of psoriasis. Related to this discussion is the question on the treatment of PPP. Should the treatment of PPP follow the guidelines for psoriasis or is it a disease that has to be treated in a different way? The purpose of this editorial is to review the differences between PPP and psoriasis and to understand these differences with respect to the pathogenesis and treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20687846     DOI: 10.3109/09546631003636817

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  16 in total

1.  Throat Infections are Associated with Exacerbation in a Substantial Proportion of Patients with Chronic Plaque Psoriasis.

Authors:  Ragna H Thorleifsdottir; Jenna H Eysteinsdóttir; Jón H Olafsson; Martin I Sigurdsson; Andrew Johnston; Helgi Valdimarsson; Bardur Sigurgeirsson
Journal:  Acta Derm Venereol       Date:  2016-08-23       Impact factor: 4.437

2.  Pustulotic Arthro-Osteitis (Sonozaki Syndrome): A Case Report and Review of Literature.

Authors:  Reyhan Kose; Taskin Senturk; Gokhan Sargin; Songul Cildag; Yasemin Kara
Journal:  Eurasian J Med       Date:  2018-02-01

3.  Risks of Comorbidities in Patients With Palmoplantar Pustulosis vs Patients With Psoriasis Vulgaris or Pompholyx in Korea.

Authors:  Dong Hyo Kim; Jin Yong Lee; Soo Ick Cho; Seong Jin Jo
Journal:  JAMA Dermatol       Date:  2022-06-01       Impact factor: 11.816

Review 4.  Tonsillectomy as a treatment for psoriasis: a review.

Authors:  Wiggin Wu; Maya Debbaneh; Homayoun Moslehi; John Koo; Wilson Liao
Journal:  J Dermatolog Treat       Date:  2013-11-27       Impact factor: 3.359

5.  Efficacy and Safety of Guselkumab, an Anti-interleukin 23 Monoclonal Antibody, for Palmoplantar Pustulosis: A Randomized Clinical Trial.

Authors:  Tadashi Terui; Satomi Kobayashi; Yukari Okubo; Masamoto Murakami; Keiichiro Hirose; Hiroshi Kubo
Journal:  JAMA Dermatol       Date:  2018-03-01       Impact factor: 10.282

6.  Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database.

Authors:  Kiyoshi Kubota; Yukari Kamijima; Tsugumichi Sato; Nobuhiro Ooba; Daisuke Koide; Hajime Iizuka; Hidemi Nakagawa
Journal:  BMJ Open       Date:  2015-01-14       Impact factor: 2.692

7.  Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis Vulgaris.

Authors:  Robert Bissonnette; Mayte Suárez-Fariñas; Xuan Li; Kathleen M Bonifacio; Carrie Brodmerkel; Judilyn Fuentes-Duculan; James G Krueger
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

8.  Are interleukin-15 and -22 a new pathogenic factor in pustular palmoplantar psoriasis?

Authors:  Aleksandra Lesiak; Igor Bednarski; Marta Pałczyńska; Ewelina Kumiszcza; Marzena Kraska-Gacka; Anna Woźniacka; Joanna Narbutt
Journal:  Postepy Dermatol Alergol       Date:  2016-10-21       Impact factor: 1.837

Review 9.  Guselkumab for the Treatment of Palmoplantar Pustulosis: A Japanese Perspective.

Authors:  Toshiyuki Yamamoto
Journal:  Clin Pharmacol       Date:  2021-06-23

Review 10.  Pustular Psoriasis: The Dawn of a New Era.

Authors:  Hervez Bachelez
Journal:  Acta Derm Venereol       Date:  2020-01-30       Impact factor: 3.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.